


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+3.86%
-2.89%
-0.77%
AUTL
Autolus Therapeutics plc
$1.28
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
Chart
$1.62 (-20.99%)
$1.75 (-26.86%)
$2.32 (-44.83%)
$3.27 (-60.86%)
AUTL has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

AUTL overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a weak earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
AUTL Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
AUTL Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is AUTL current stock price?
What are AUTL stock strengths?
What risks are associated with AUTL stock?
When is AUTL next earnings report?
What is AUTL market cap and volume?
What is AUTL's current Stock IQ?
Should I buy AUTL stock right now?
Is AUTL a Strong Buy right now?
What does a 'Strong Buy' rating mean for AUTL?
What does a 'Strong Sell' rating mean for AUTL?
What factors influence AUTL's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+3.86%
-2.89%
-0.77%
AUTL
Autolus Therapeutics plc
Current Price
$1.28
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Chart
$1.62 (-20.99%)
$1.75 (-26.86%)
$2.32 (-44.83%)
$3.27 (-60.86%)
AUTL Analysts Opinion
AUTL Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a weak earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
AUTL Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
AUTL Street Sentiment is bullish and have positive views on the near-term outlook
AUTL has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

Average key support and resistance price levels.
AUTL Latest Analysis
Autolus Therapeutics GAAP EPS of -$0.30 misses by $0.08 revenue of $21.14M misses by $0.17M.
Wed Nov 12, 2025
Earnings Scheduled For November 12 2025. . Hudbay Minerals (NYSE:HBM) is projected to report quarterly earnings at $0.07 per share on revenue of $411.46 million. . European Wax Center (NASDAQ:) is estimated to report quarterly earnings at $0.11 per share on revenue of $52.59 million. . Boyd Group Services (NYSE:BGSI) is projected to report quarterly earnings at $0.66 per share on revenue of $792.07 million. . Katapult Holdings (NASDAQ:KPLT) is expected to report quarterly loss at $0.21 per share
Wed Nov 12, 2025
Needham Reiterates Autolus Therapeutics plc - Depositary Receipt (AUTL) Buy Recommendation. Fintel reports that on November 3 2025 Needham reiterated coverage of Autolus Therapeutics plc - Depositary Receipt (NasdaqGS:AUTL) with a Buy recommendation. Analyst Price Forecast Suggests 520.53% Upside
Tue Nov 4, 2025
Why is Autolus Therapeutics plc (AUTL) One of the Best Stocks Under $5 With Highest Upside Potential?. Autolus Therapeutics plc (NASDAQ:AUTL) is one of the best stocks under $5 with highest upside potential. Autolus Therapeutics plc (NASDAQ:AUTL) received a Buy rating from Needham analyst Gil Blum on October 27 who set a $10 price target on the stock and based the optimistic outlook on the companys promising clinical data. The rating update [….]
Fri Oct 31, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
AUTL Stock trends
AUTL Stock performance
AUTL Stock analysis
AUTL investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.